Advanced

Immunosuppression with ALG and CsA is first line treatment in children with SAA lacking an HLA identical sibling.

Békássy, Albert LU ; Locasciulli, Anna; Marsh, Judith C W; Socié, Gerard; Fuehrer, Monika and Passweg, Jakob (2005) In Pediatric Blood & Cancer 45(3). p.359-360
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Pediatric Blood & Cancer
volume
45
issue
3
pages
359 - 360
publisher
John Wiley and Sons Inc.
external identifiers
  • wos:000230740000026
  • scopus:23044509687
ISSN
1545-5017
DOI
10.1002/pbc.20418
language
English
LU publication?
yes
id
1a963138-aa9b-4074-bf37-c3a5ea421166 (old id 140180)
alternative location
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15940724
date added to LUP
2007-07-20 16:25:45
date last changed
2017-01-01 04:26:27
@article{1a963138-aa9b-4074-bf37-c3a5ea421166,
  author       = {Békássy, Albert and Locasciulli, Anna and Marsh, Judith C W and Socié, Gerard and Fuehrer, Monika and Passweg, Jakob},
  issn         = {1545-5017},
  language     = {eng},
  number       = {3},
  pages        = {359--360},
  publisher    = {John Wiley and Sons Inc.},
  series       = {Pediatric Blood & Cancer},
  title        = {Immunosuppression with ALG and CsA is first line treatment in children with SAA lacking an HLA identical sibling.},
  url          = {http://dx.doi.org/10.1002/pbc.20418},
  volume       = {45},
  year         = {2005},
}